Futura Medical (GB:FUM) has released an update.
Futura Medical PLC has successfully passed all resolutions at its Annual General Meeting, with shareholders expressing strong support for the company’s direction. The resolutions included the reappointment of directors, auditors, and the authorization for the company to allot shares and disapply pre-emption rights. The consumer healthcare company is known for its innovative sexual health products, such as Eroxon®, a fast-acting gel for Erectile Dysfunction that’s gaining traction globally.
For further insights into GB:FUM stock, check out TipRanks’ Stock Analysis page.
